Dermatitis after suspected imatinib-levothyroxine interaction in a patient with gastrointestinal stromal tumor.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Works in Cancer Chemotherapy & Pharmacology, 2008, Vol 61, Issue 6
Results: 24
1
2
A phase I clinical trial of low-dose interferon-alpha-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
3
A Phase 1 dose-escalation trial of glucosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
4
The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors.
- Published in:
- 2008
- By:
- Publication type:
- journal article
5
IPI-504, a novel and soluble HSP-90 inhibitor, blocks the unfolded protein response in multiple myeloma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 923, doi. 10.1007/s00280-007-0546-0
- By:
- Publication type:
- Article
6
Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 903, doi. 10.1007/s00280-008-0711-0
- By:
- Publication type:
- Article
7
A novel class of tubulin inhibitors that exhibit potent antiproliferation and in vitro vessel-disrupting activity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 953, doi. 10.1007/s00280-007-0549-x
- By:
- Publication type:
- Article
8
Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 1075, doi. 10.1007/s00280-007-0545-1
- By:
- Publication type:
- Article
9
Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 965, doi. 10.1007/s00280-007-0551-3
- By:
- Publication type:
- Article
10
Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 989, doi. 10.1007/s00280-007-0555-z
- By:
- Publication type:
- Article
11
New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 973, doi. 10.1007/s00280-007-0553-1
- By:
- Publication type:
- Article
12
Suppression of Bcl-xL expression by a novel tumor-specific RNA interference system inhibits proliferation and enhances radiosensitivity in prostatic carcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 943, doi. 10.1007/s00280-007-0548-y
- By:
- Publication type:
- Article
13
Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 979, doi. 10.1007/s00280-007-0554-0
- By:
- Publication type:
- Article
14
A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 1019, doi. 10.1007/s00280-007-0559-8
- By:
- Publication type:
- Article
15
Dermatitis after suspected imatinib–levothyroxine interaction in a patient with gastrointestinal stromal tumor.
- Published in:
- 2008
- By:
- Publication type:
- Letter
16
Plasma and cerebrospinal fluid pharmacokinetics of the novel tetrahydroisoquinoline EDL-155 in rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 1037, doi. 10.1007/s00280-007-0563-z
- By:
- Publication type:
- Article
17
Disruption of Golgi processing by 2-phenyl benzimidazole analogs blocks cell proliferation and slows tumor growth.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 1045, doi. 10.1007/s00280-007-0564-y
- By:
- Publication type:
- Article
18
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 1059, doi. 10.1007/s00280-007-0556-y
- By:
- Publication type:
- Article
19
A phase I clinical trial of low-dose interferon-α-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 1069, doi. 10.1007/s00280-007-0568-7
- By:
- Publication type:
- Article
20
The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 997, doi. 10.1007/s00280-007-0557-x
- By:
- Publication type:
- Article
21
Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 1007, doi. 10.1007/s00280-007-0558-9
- By:
- Publication type:
- Article
22
Determination of pharmacokinetic values of calicheamicin-antibody conjugates in mice by plasmon resonance analysis of small (5 μl) blood samples.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 1027, doi. 10.1007/s00280-007-0560-2
- By:
- Publication type:
- Article
23
Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 911, doi. 10.1007/s00280-007-0544-2
- By:
- Publication type:
- Article
24
Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q<sub>10</sub>, Niacin and Riboflavin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 933, doi. 10.1007/s00280-007-0547-z
- By:
- Publication type:
- Article